2022
DOI: 10.1186/s13256-021-03237-y
|View full text |Cite
|
Sign up to set email alerts
|

Giant carotid chemodectoma treated with a combination of surgery and CyberKnife radiotherapy: a case report and review of the literature

Abstract: Background Paragangliomas are rare vascular neuroendocrine tumors that develop in the extra-adrenal paraganglion tissue. They occur most commonly at the carotid bifurcation, where they are known as carotid body tumors. Most paragangliomas are benign, locally aggressive, infiltrative tumors. Approximately 10% of patients with paragangliomas develop distant metastases, 10% present with multiple or bilateral tumors (mostly carotid body tumors), and 10% have a family history of paragangliomas. The … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 21 publications
0
1
0
Order By: Relevance
“…There is no consensus to define PGs as “giant”. Main et al [ 30 ], in their case report, considered giant PG with a volume of 93.553 cm 3 that was treated with only SR, whereas López-Arcas et al [ 52 ] reported a case of combination treatment in giant PG of a maximum diameter of 4 cm, removed surgically after embolization and treated with FSRT performed with a coverage dose of 14 Gy at an isodose of 83%. Other studies evaluated the efficacy of RT in unresectable or bulky diseases[ 53 , 54 ].…”
Section: Discussionmentioning
confidence: 99%
“…There is no consensus to define PGs as “giant”. Main et al [ 30 ], in their case report, considered giant PG with a volume of 93.553 cm 3 that was treated with only SR, whereas López-Arcas et al [ 52 ] reported a case of combination treatment in giant PG of a maximum diameter of 4 cm, removed surgically after embolization and treated with FSRT performed with a coverage dose of 14 Gy at an isodose of 83%. Other studies evaluated the efficacy of RT in unresectable or bulky diseases[ 53 , 54 ].…”
Section: Discussionmentioning
confidence: 99%
“…While most carotid body tumors are benign, there is a potential for malignancy, accounting for approximately 2 %–12.5 % of cases [ 4 ]. The clinical manifestations of both benign and malignant CBTs often share similarities, producing local compressive symptoms such as hearing loss, ear pain, tinnitus, neck mass, or cranial neuropathy leading to swallowing difficulty, facial weakness, and hoarseness [ 6 ].…”
Section: Introductionmentioning
confidence: 99%